Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019

While confirmed cases of the deadly coronavirus disease 2019 (COVID-19) have exceeded 4.7 million globally, scientists are pushing forward with efforts to develop vaccines and treatments in an attempt to slow the pandemic and lessen the disease's damage. Although no proven effective therapies f...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Cosimo, Serena, Malfettone, Andrea, Pérez-García, José M., Llombart-Cussac, Antonio, Miceli, Rosalba, Curigliano, Giuseppe, Cortés, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Current Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269953/
https://www.ncbi.nlm.nih.gov/pubmed/32544799
http://dx.doi.org/10.1016/j.ejca.2020.05.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269953/
https://www.ncbi.nlm.nih.gov/pubmed/32544799
http://dx.doi.org/10.1016/j.ejca.2020.05.026

Ejemplares similares